Wade T Swenson Ii, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 49725 County 83, Staples, MN 56479 Phone: 218-894-1515 Fax: 218-894-8767 |
John Joseph Weitz, Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 49725 County 83, Staples, MN 56479 Phone: 218-894-1515 Fax: 218-894-1316 |
News Archive
Neurocrine Biosciences, Inc. today announced that it has entered into an exclusive collaboration and licensing agreement for the development and commercialization of its VMAT2 inhibitor, NBI-98854, in Japan and other select Asian markets with Mitsubishi Tanabe Pharma Corporation.
New research suggests that physicians can distinguish between a type of thyroid cancer and an identical-looking, non-cancerous thyroid condition by simply determining the activity of three genes.
The results of a major international study presented at the European Society of Cardiology Congress in Stockholm and published simultaneously in The Lancet show, for the first time, that selectively lowering heart rate with a novel medication, ivabradine, significantly reduces risk of death and hospitalization for patients with heart failure. This also resolves a longstanding debate about whether lowering heart rate itself can actually lower the risk of heart disease progression.
A team of researchers from the Netherlands demonstrated that prophylactic treatment with a high dose of human convalescent plasma or by using concentrated monoclonal antibodies could protect against disease following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in an animal model. However, no protective effect was observed with a ten-fold lower dose of convalescent plasma. The results are currently available on the bioRxiv* preprint server.
› Verified 4 days ago